Cofirasersen sodium
Cofirasersen sodium is designed to reduce the expression of ENaC in the lung. ENaC is a sodium transport channel and believed to be hyperactive in cystic fibrosis, which is caused by mutations in the cystic fibrosis transmembrane regulator gene.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Formel: C172H202N57Na16O88P15S15
- Molecular Weight:5437.55 (free acid)
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Chemical Information
-
Molecular Weight 5437.55 (free acid)
-
Formel C172H202N57Na16O88P15S15
-
SMILES
[Cofirasersen (sodium)]
-
Synonyms
ION-827359 sodium
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)